Table 3 Adjusted cancer patient survival hazard ratio for patients with cardiovascular disease prior to diagnosis compared to those with no prior history of cardiovascular disease: Patients diagnosed 2011-2014, followed up to the end of 2019
From: Survival of cancer patients with pre-existing heart disease
Cancer type | Adjusted hazard ratio (95% CI)a – cardiovascular disease prior to diagnosis vs. no prior history of cardiovascular diseases | |
|---|---|---|
Observed survival (i.e. death from any cause) | Cancer-specific survival (i.e. death from cancer only) | |
All cancers (ex NMSC) | 1.36 (1.26, 1.46) | 1.28 (1.18, 1.40) |
Colorectal cancer | 1.26 (1.03, 1.53) | 1.15 (0.91, 1.45) |
Lung cancer | 1.35 (1.13, 1.60) | 1.28 (1.07, 1.54) |
Female breast cancer | 1.42 (1.03, 1.94) | 1.51 (1.01, 2.26) |
Prostate cancer | 1.52 (1.19, 1.94) | 1.74 (1.28, 2.35) |